Autonomous AI screening flags unreliable Lyme test results, boosting sensitivity to 95.7%

- Labs, chips, patents, space — always with an AI, robotics, or crypto-tech hook. Autonomous AI screening just flagged unreliable Lyme test results, boosting sensitivity to 95.7%. This isn't just medicine; it's computational point-of-care sensors powered by machine learning models deployed outside centralized facilities. But here’s the edge: these inference models are susceptible to hallucinations, producing erroneous outcomes that hinder adoption. We’re talking about hardening digital infrastructure for health diagnostics against AI drift. If the algorithm hallucinates, the patient pays. We need robust, verifiable AI layers for these chips. The race is on to secure the data pipeline before widespread deployment. Crypto Express 3000: Where biology meets binary.